JP4414711B2 - Active oxygen scavenger and method for producing the same - Google Patents
Active oxygen scavenger and method for producing the same Download PDFInfo
- Publication number
- JP4414711B2 JP4414711B2 JP2003336062A JP2003336062A JP4414711B2 JP 4414711 B2 JP4414711 B2 JP 4414711B2 JP 2003336062 A JP2003336062 A JP 2003336062A JP 2003336062 A JP2003336062 A JP 2003336062A JP 4414711 B2 JP4414711 B2 JP 4414711B2
- Authority
- JP
- Japan
- Prior art keywords
- active oxygen
- anthocyanin
- acerola
- decomposition
- oxygen scavenger
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940123973 Oxygen scavenger Drugs 0.000 title claims description 30
- 238000004519 manufacturing process Methods 0.000 title claims description 15
- 235000010208 anthocyanin Nutrition 0.000 claims description 58
- 239000004410 anthocyanin Substances 0.000 claims description 58
- 229930002877 anthocyanin Natural products 0.000 claims description 58
- 150000004636 anthocyanins Chemical class 0.000 claims description 58
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 52
- 239000000049 pigment Substances 0.000 claims description 50
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 26
- 229930003268 Vitamin C Natural products 0.000 claims description 26
- 239000011718 vitamin C Substances 0.000 claims description 26
- 235000019154 vitamin C Nutrition 0.000 claims description 26
- 229910052751 metal Inorganic materials 0.000 claims description 18
- 239000002184 metal Substances 0.000 claims description 18
- 238000000354 decomposition reaction Methods 0.000 description 43
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 35
- 240000003394 Malpighia glabra Species 0.000 description 34
- 235000014837 Malpighia glabra Nutrition 0.000 description 34
- 239000000047 product Substances 0.000 description 30
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 29
- 239000001301 oxygen Substances 0.000 description 29
- 229910052760 oxygen Inorganic materials 0.000 description 29
- 230000002000 scavenging effect Effects 0.000 description 27
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000000975 dye Substances 0.000 description 14
- 239000000284 extract Substances 0.000 description 12
- -1 and as a result Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 9
- 229910052742 iron Inorganic materials 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 235000015203 fruit juice Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000007857 degradation product Substances 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000005562 fading Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000012239 silicon dioxide Nutrition 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 108010093894 Xanthine oxidase Proteins 0.000 description 3
- 102100033220 Xanthine oxidase Human genes 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 229940100486 rice starch Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 230000036962 time dependent Effects 0.000 description 3
- 229940100445 wheat starch Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- COAWNPJQKJEHPG-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-1lambda^{4}-chromen-1-ylium chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 COAWNPJQKJEHPG-UHFFFAOYSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 2
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 229950008138 carmellose Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 235000007336 cyanidin Nutrition 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000001341 hydroxy propyl starch Substances 0.000 description 2
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 2
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 229940116317 potato starch Drugs 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- KJHJAABRDASKAF-UHFFFAOYSA-N 3,7-dihydropurine-2,6-dione Chemical compound OC1=NC(O)=C2N=CNC2=N1.O=C1NC(=O)NC2=C1NC=N2 KJHJAABRDASKAF-UHFFFAOYSA-N 0.000 description 1
- VCUVETGKTILCLC-UHFFFAOYSA-N 5,5-dimethyl-1-pyrroline N-oxide Chemical compound CC1(C)CCC=[N+]1[O-] VCUVETGKTILCLC-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 229920002675 Polyoxyl Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 240000007326 Thaumatococcus daniellii Species 0.000 description 1
- 235000005266 Thaumatococcus daniellii Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 229920003144 amino alkyl methacrylate copolymer Polymers 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 201000003740 cowpox Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- ZADYMNAVLSWLEQ-UHFFFAOYSA-N magnesium;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[Mg+2].[Si+4] ZADYMNAVLSWLEQ-UHFFFAOYSA-N 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000006395 oxidase reaction Methods 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- 229930015721 peonidin Natural products 0.000 description 1
- 235000006404 peonidin Nutrition 0.000 description 1
- OGBSHLKSHNAPEW-UHFFFAOYSA-N peonidin chloride Chemical compound [Cl-].C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 OGBSHLKSHNAPEW-UHFFFAOYSA-N 0.000 description 1
- 229930015717 petunidin Natural products 0.000 description 1
- 235000006384 petunidin Nutrition 0.000 description 1
- QULMBDNPZCFSPR-UHFFFAOYSA-N petunidin chloride Chemical compound [Cl-].OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 QULMBDNPZCFSPR-UHFFFAOYSA-N 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003253 viricidal effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
Description
本発明は、アントシアニン系色素分解物を含有する活性酸素消去剤及びその製造方法に関する。 The present invention relates to an active oxygen scavenger containing an anthocyanin pigment decomposition product and a method for producing the same.
活性酸素とは、反応性に富んだエネルギー状態にある酸素で、具体的には、OH-(ヒドロキシラジカル)、O2 -(スーパーオキシドアニオン)及びH2O2(過酸化水素)を指す。これらは生体内において種々の反応に関与し、疾病や老化の原因となり得ることが報告されている。 Active oxygen is oxygen in an energy state rich in reactivity, and specifically refers to OH − (hydroxy radical), O 2 − (superoxide anion), and H 2 O 2 (hydrogen peroxide). It has been reported that these are involved in various reactions in vivo and can cause diseases and aging.
例えば、生体内に細菌やウイルスが侵入すると、当該局所に食細胞である好中球、単球、マクロファージが遊走し、侵入した細菌やウイルスに対し食作用を開始し、引き続きO2 -を生産して、このO2 -が殺菌、殺ウイルス及び殺感染細胞作用を及ぼし、生体の自己防衛に当たる。しかし、O2 -が過剰に存在すると、正常な細胞や組織に対して障害を引き起こし、関節リウマチ、動脈硬化、糖尿病、肝炎、腎炎等の疾病、また、皮膚炎、シミ、シワ、湿疹、ソバカス等、美容上の障害となる諸症状が引き起こされる。 For example, when bacteria and viruses into the body from entering, neutrophils to the local is phagocytes, monocytes, macrophages migrate to initiate phagocytosis against invading bacteria and viruses, subsequently O 2 - production of Thus, this O 2 − acts as a bactericidal, virucidal and infected cell, and is a self-protection of the living body. However, excessive O 2 − causes damage to normal cells and tissues, such as rheumatoid arthritis, arteriosclerosis, diabetes, hepatitis, nephritis, dermatitis, blemishes, wrinkles, eczema, buckwheat Various symptoms that cause cosmetic problems are caused.
近年、上記諸疾患の改善及び予防のために、活性酸素消去活性を有する物質を、薬学的、食品科学的又は香粧品科学的な見地から、天然物、醗酵物又は化成品からスクリーニングする作業が活発に行われ、その結果、かなりの数の活性酸素消去剤が知られるようになった。 In recent years, in order to ameliorate and prevent the above-mentioned diseases, there has been an operation of screening substances having active oxygen scavenging activity from natural products, fermented products, or chemical products from the viewpoint of pharmaceutical, food science or cosmetic science. As a result, a significant number of active oxygen scavengers have become known.
例えば、特許文献1では紅花の葉及び/又は茎由来の水溶性抗酸化剤が、特許文献2ではスモモ、セイヨウナツユキソウ、ベンガルカラタチ、ミラクルベリー、ヤーバサンタ、レモングラスから選ばれる1種以上の植物抽出物を含有する活性酸素消去剤及び化粧料組成物が、特許文献3では木棉及び/又は黄花倒水蓮からの抽出物を有効成分として含有する活性酸素消去剤が開示されている。
For example,
一方、アントシアニン系色素は、植物等に多く存在する色素であり、その鮮やかな色調を利用して着色料として用いられている。また、アントシアニン系色素は活性酸素消去活性を有することが知られており、サプリメント等の健康食品や飲料に多く利用されている。アントシアニン系色素は、一般的に不安定な色素であり、特にアルカリ条件下において、C環が開環し分解され、退色が起こる。また、温度や光等の影響によっても容易に分解され退色が起こるが、酸性下では比較的安定である。 On the other hand, anthocyanin-based pigments are pigments that are abundant in plants and the like, and are used as coloring agents by utilizing their vivid colors. Anthocyanin pigments are known to have active oxygen scavenging activity and are widely used in health foods and beverages such as supplements. Anthocyanin dyes are generally unstable dyes, and particularly under alkaline conditions, the C ring is opened and decomposed, causing discoloration. In addition, although it is easily decomposed and discolored due to the influence of temperature, light, etc., it is relatively stable under acidic conditions.
キントラノオ科ヒイラギトラノオ属の熱帯果実であるアセロラは、アントシアニン系色素を多く含む植物である。アセロラの果実中は酸性であるため、光や熱を与えなければ、アントシアニン系色素は安定なはずである。しかし、アセロラには、アントシアニン系色素の他にビタミンCが果実100g当り約1,500mgと非常に多く含まれ、その影響で、光や熱を与えなくてもアントシアニン系色素が容易に分解し退色する。また、アセロラ中に少量含まれる鉄分によりさらに分解が促進されることがわかっている。アセロラ中で起こるビタミンC及び/又は金属によるアントシアニン系色素の分解・退色は、pH、温度、光等による分解・退色とはメカニズムが異なるが、そのメカニズムが詳細に調べられた例はほとんどなく、アントシアニン系色素の活性酸素消去活性が分解・退色後に保持されているのかどうかも知られていない。
本発明の目的は、活性酸素消去剤及びその製造方法を提供することである。
本発明の目的は、アセロラ由来のアントシアニン系色素分解物を含有する活性酸素消去剤及びその製造方法を提供することである。
本発明の目的はさらに、アントシアニン系色素をビタミンC及び/又は金属で分解したアントシアニン系色素分解物を含有する活性酸素消去剤及びその製造方法を提供することである。
An object of the present invention is to provide an active oxygen scavenger and a method for producing the same.
An object of the present invention is to provide an active oxygen scavenger containing an anthocyanin pigment decomposition product derived from acerola and a method for producing the same.
Another object of the present invention is to provide an active oxygen scavenger containing an anthocyanin pigment decomposition product obtained by decomposing an anthocyanin pigment with vitamin C and / or a metal, and a method for producing the same.
本発明者らは、前記課題を解決するために鋭意検討した結果、アセロラ由来のアントシアニン系色素分解物が活性酸素消去活性を有していることを見出した。
本発明者らはまた、アントシアニン系色素をビタミンC及び/又は金属で分解した分解物が活性酸素消去活性を有していることを見出した。
本発明者らはさらに、これらの分解物の分解が進むにつれ、活性酸素消去活性が上昇することを見出した。
As a result of intensive studies in order to solve the above problems, the present inventors have found that an anthocyanin-based pigment decomposition product derived from acerola has an active oxygen scavenging activity.
The present inventors have also found that a decomposition product obtained by decomposing an anthocyanin pigment with vitamin C and / or metal has active oxygen scavenging activity.
Furthermore, the present inventors have found that the active oxygen scavenging activity increases as the decomposition of these decomposition products proceeds.
アントシアニン系色素の分解については、これまでにアルキルペルオキシルラジカルをアントシアニン系色素に反応させることにより、アントシアニン系色素が分解してプロトカクキュ酸を生じさせる方法が知られている(Lipids, Vol.31, No.12 (1996), pp1259-1263)。プロトカテキュ酸は強い活性酸素消去剤であり、従ってこのような手段によりアントシアニン系色素を分解した場合は、その分解物も強い活性酸素消去活性を保持することが予想される。 Regarding the decomposition of anthocyanin dyes, there has been known a method in which an anthocyanin dye is decomposed to produce protocuccinic acid by reacting an alkylperoxyl radical with an anthocyanin dye (Lipids, Vol. 31, No. 12 (1996), pp1259-1263). Protocatechuic acid is a strong active oxygen scavenger. Therefore, when an anthocyanin dye is decomposed by such means, it is expected that the decomposed product also retains a strong active oxygen scavenging activity.
しかし、本発明では、アントシアニン系色素の分解の手段として、アントシアニン系色素にビタミンC及び/又は金属を作用させており、また本発明のアントシアニン系色素分解物について成分分析を行ったところ、プロトカクキュ酸は生成されていないことがわかった。このことから、上記の公知文献と本発明とでは、アントシアニン系色素分解のメカニズムが異なることが明らかである。さらに、アントシアニン系色素分解物の分解が進むにつれ活性酸素消去活性が上昇することは、これまでに見出されていなかった。 However, in the present invention, vitamin C and / or metal is allowed to act on the anthocyanin pigment as a means for decomposing the anthocyanin pigment, and component analysis was performed on the anthocyanin pigment degradation product of the present invention. Was found not to have been generated. From this, it is clear that the known literature and the present invention have different anthocyanin pigment decomposition mechanisms. Furthermore, it has not been found so far that the active oxygen scavenging activity increases as the decomposition of the anthocyanin pigment decomposition product proceeds.
本発明は、以下の発明を包含する。
(1)アセロラ由来のアントシアニン系色素分解物を有効成分として含有する活性酸素消去剤。
(2)アセロラ由来のアントシアニン系色素を分解することを含む、活性酸素消去剤の製造方法。
(3)アセロラ由来の果汁又はその抽出物もしくは処理物を30℃〜90℃で処理して得られる処理物を有効成分として含有する活性酸素消去剤。
(4)アントシアニン系色素をビタミンC及び/又は金属で分解したアントシアニン系色素分解物を含有する活性酸素消去剤。
(5)アントシアニン系色素をビタミンC及び/又は金属で分解することを含む活性酸素消去剤の製造方法。
The present invention includes the following inventions.
(1) An active oxygen scavenger which contains an anthocyanin pigment decomposition product derived from acerola as an active ingredient.
(2) A method for producing an active oxygen scavenger comprising decomposing an anthocyanin pigment derived from acerola.
(3) An active oxygen scavenger containing, as an active ingredient, a processed product obtained by processing an acerola-derived fruit juice or an extract or processed product thereof at 30 ° C to 90 ° C.
(4) An active oxygen scavenger containing an anthocyanin pigment decomposition product obtained by decomposing an anthocyanin pigment with vitamin C and / or metal.
(5) A method for producing an active oxygen scavenger comprising decomposing an anthocyanin pigment with vitamin C and / or metal.
本発明の活性酸素消去剤は、活性酸素消去活性を有するアントシアニン系色素分解物を含有しており、活性酸素に関係する種々の疾病や老化を予防・治療するのに有効である。
本発明はまた、従来用いられていなかったアントシアニン系色素分解物の用途を提供するものである。
本発明で提供されるアセロラ由来の活性酸素消去剤は、天然成分由来のため、副作用の問題が少ない。
The active oxygen scavenger of the present invention contains an anthocyanin pigment decomposition product having active oxygen scavenging activity, and is effective in preventing and treating various diseases and aging related to active oxygen.
The present invention also provides the use of an anthocyanin-based pigment decomposition product that has not been conventionally used.
Since the active oxygen scavenger derived from acerola provided in the present invention is derived from natural ingredients, there are few problems of side effects.
アセロラ由来のアントシアニン系色素分解物を含有する活性酸素消去剤及びその製造方法
本発明は、アセロラ由来のアントシアニン系色素分解物を含有する活性酸素消去剤及びその製造方法に関する。
本発明で用いるアセロラの生産地や品種は特に制限されないが、生産地としては、例えば沖縄、ブラジルが挙げられる。
本発明の活性酸素消去剤として、アセロラ果実を搾汁して得られるアセロラ果汁をそのまま用いることができるが、果実を破砕、粉砕等により粉末化処理したものを用いてもよいし、その抽出物又は処理物として用いてもよい。
Active oxygen scavenger and a manufacturing method thereof The present invention contain anthocyanin dye degradation product derived from acerola, active oxygen scavenger, and a method for producing the same containing anthocyanin pigment decomposition product derived from acerola.
The production area and variety of acerola used in the present invention are not particularly limited, but examples of production areas include Okinawa and Brazil.
As the active oxygen scavenger of the present invention, the acerola fruit juice obtained by squeezing the acerola fruit can be used as it is, but the fruit may be pulverized, pulverized or the like, or an extract thereof may be used. Or you may use as a processed material.
抽出物又はその処理物として用いる場合、抽出に用いる有機溶媒は、親水性有機溶媒が好ましい。親水性有機溶媒として、例えば、メチルアルコール、エチルアルコール、グリセリン、プロピレングリコール、1,3-ブチレングリコール等のアルコール、アセトン、テトラヒドロフラン、アセトニトリル、1,4-ジオキサン、ピリジン、ジメチルスルホキシド、N,N-ジメチルホルムアミド、酢酸等の公知の有機溶媒が挙げられる。特にメチルアルコールを用いて抽出することが好ましい。上記の親水性有機溶媒、特にメチルアルコール及びエチルアルコールは、水との混合物として用いることが好ましい。 When used as an extract or a processed product thereof, the organic solvent used for extraction is preferably a hydrophilic organic solvent. Examples of the hydrophilic organic solvent include alcohols such as methyl alcohol, ethyl alcohol, glycerin, propylene glycol, and 1,3-butylene glycol, acetone, tetrahydrofuran, acetonitrile, 1,4-dioxane, pyridine, dimethyl sulfoxide, N, N- Known organic solvents such as dimethylformamide and acetic acid can be mentioned. It is particularly preferable to extract using methyl alcohol. The hydrophilic organic solvent, particularly methyl alcohol and ethyl alcohol, are preferably used as a mixture with water.
抽出条件は特に限定されないが、好ましい温度範囲は5℃〜90℃、特に20℃〜40℃である。抽出時間は1時間〜10時間程度、特に1時間〜2時間程度が好ましく、また抽出に使用する溶媒量は原料に対して質量比で1倍量〜20倍量が好ましい。
抽出後、ろ過あるいは遠心分離により抽出残渣を除き抽出液を得る。この抽出液は必要に応じて濃縮処理を行うこともできる。
The extraction conditions are not particularly limited, but a preferable temperature range is 5 ° C to 90 ° C, particularly 20 ° C to 40 ° C. The extraction time is preferably about 1 hour to 10 hours, particularly about 1 hour to 2 hours, and the amount of solvent used for extraction is preferably 1 to 20 times by mass with respect to the raw material.
After extraction, the extraction residue is removed by filtration or centrifugation to obtain an extract. This extract may be concentrated as necessary.
このようにして得られたアセロラ果汁又はその抽出物もしくは処理物にはアントシアニン系色素、ビタミンC及び鉄が含まれており、ビタミンC及び/又は金属を添加しなくても、アントシアニン系色素をビタミンC及び/又は鉄により分解させて退色させることができる。しかし、アセロラ果汁又はその抽出物もしくは処理物に、ビタミンC及び/又は金属を添加してもよい。 The acerola juice obtained as described above or an extract or processed product thereof contains anthocyanin pigment, vitamin C and iron, and anthocyanin pigment can be added to vitamin without adding vitamin C and / or metal. It can be discolored by decomposition with C and / or iron. However, vitamin C and / or metal may be added to acerola juice or an extract or processed product thereof.
分解の条件は、限定されるわけではないが、例えば分解温度として30℃〜90℃が好ましい。また分解時間は分解温度により適宜変更でき、例えば分解温度が30℃といった低温条件であれば10日〜50日、分解温度が90℃といった高温条件であれば1時間〜5時間程度が好ましい。特に好ましい分解条件は、30℃〜50℃の低温度下で、10日〜50日である。 The decomposition conditions are not limited, but for example, the decomposition temperature is preferably 30 ° C to 90 ° C. The decomposition time can be appropriately changed depending on the decomposition temperature. For example, it is preferably about 10 to 50 days if the decomposition temperature is a low temperature condition of 30 ° C., and preferably about 1 to 5 hours if the decomposition temperature is a high temperature condition of 90 ° C. Particularly preferable decomposition conditions are 10 to 50 days at a low temperature of 30 to 50 ° C.
アントシアニン系色素分解物を含有する活性酸素消去剤及びその製造方法
本発明者らは、一般的なアントシアニン系色素をビタミンC及び/又は金属で分解して得られる分解物も活性酸素消去活性を有し、さらにこの分解物も、分解が進むにつれ、活性酸素消去活性が上昇することを見出した。
An active oxygen scavenger containing an anthocyanin pigment degradation product and a process for producing the same The present inventors have also disclosed that a degradation product obtained by decomposing a general anthocyanin pigment with vitamin C and / or metal also has an active oxygen scavenging activity. Furthermore, it was found that the active oxygen scavenging activity of this decomposed product increases as the decomposition proceeds.
アントシアニン系色素としては、シアニジン、マルビジン、デルフィニジン、ペチュニジン、ペオニジン、ペラルゴニジンあるいはそれらをアグリコンとする配糖体が挙げられるが、特にシアニジンあるいはその配糖体が好ましい。
ビタミンCとしては、通常入手できるものを用いればよい。
Examples of the anthocyanin dye include cyanidin, malvidin, delphinidin, petunidin, peonidin, pelargonidin, and glycosides containing them as aglycones, and cyanidin or glycosides thereof are particularly preferable.
As vitamin C, a commercially available product may be used.
分解に用いる金属としては、アントシアニン系色素の分解を促進するものであればよく、特に限定されるわけではないが、例えば、鉄や銅等の金属塩が挙げられ、特に鉄が好ましい。 The metal used for the decomposition is not particularly limited as long as it promotes the decomposition of the anthocyanin pigment, and examples thereof include metal salts such as iron and copper, and iron is particularly preferable.
アントシアニン系色素を、ビタミンC又は金属のいずれかで分解することもできるが、ビタミンC及び金属の両方を用いて分解することが好ましい。 Anthocyanin pigments can be decomposed with either vitamin C or metal, but are preferably decomposed with both vitamin C and metal.
ビタミンCの添加量は、アントシアニン系色素の5倍〜100倍、特に50倍〜100倍の量であることが好ましい。金属の添加量は、アントシアニン系色素の1/10〜1/2の範囲、特に1/10〜1/4の範囲であることが好ましい。 The amount of vitamin C added is preferably 5 to 100 times, particularly 50 to 100 times that of the anthocyanin pigment. The amount of the metal added is preferably in the range of 1/10 to 1/2, particularly in the range of 1/10 to 1/4 of the anthocyanin dye.
分解の条件は、特に限定されるわけではないが、上述のアセロラ由来のアントシアニン系色素の分解と同様に行うことができる。 The conditions for the decomposition are not particularly limited, but can be carried out in the same manner as the above-described decomposition of an anthocyanin pigment derived from acerola.
本発明のアントシアニン系色素分解物は、ビタミンCや金属との混合物のままで、活性酸素消去剤として使用できるが、製造後、残存するビタミンCや金属等を取り除く精製工程を行ってもよい。精製処理の方法として、順相又は逆相クロマトグラフィー、イオン交換クロマトグラフィー、ゲルろ過等が挙げられるが、特に逆相クロマトグラフィーの使用が好ましい。また、これらの方法を組み合わせて用いることもできる。 The anthocyanin pigment decomposition product of the present invention can be used as an active oxygen scavenger in the form of a mixture with vitamin C and metal, but may be subjected to a purification step for removing residual vitamin C and metal after production. Examples of the purification method include normal phase or reverse phase chromatography, ion exchange chromatography, gel filtration, and the like, and the use of reverse phase chromatography is particularly preferable. A combination of these methods can also be used.
用途
本発明の活性酸素消去剤は、アセロラの果汁、抽出物や精製物、又はアントシアニン系色素分解物を、公知の医薬用担体と組み合わせて製剤化することができる。投与形態としては、特に制限はなく、必要に応じ適宜選択されるが、一般には錠剤、カプセル剤、顆粒剤、細粒剤、散剤、液剤、シロップ剤、懸濁剤、乳剤、エリキシル剤等の経口剤、又は注射剤、点滴剤、坐剤、吸入剤、経皮吸収剤、経粘膜吸収剤、貼付剤、軟膏剤等の非経口剤として使用される。本発明の活性酸素消去剤の添加量は、添加対象物の種類、使用形態等の諸条件によって異なるが、通常、添加対象物全体に対し0.01質量%〜10質量%の範囲で用いることが好ましい。
Use The active oxygen scavenger of the present invention can be formulated by combining acerola juice, extract or purified product, or anthocyanin pigment decomposition product with a known pharmaceutical carrier. The dosage form is not particularly limited and is appropriately selected as necessary. In general, tablets, capsules, granules, fine granules, powders, solutions, syrups, suspensions, emulsions, elixirs, etc. It is used as oral preparations or parenteral preparations such as injections, drops, suppositories, inhalants, transdermal absorbents, transmucosal absorbents, patches, ointments and the like. The amount of the active oxygen scavenger added according to the present invention varies depending on various conditions such as the kind of the object to be added and the form of use, but it is usually preferable to use it in the range of 0.01% by mass to 10% by mass with respect to the entire object to be added. .
本発明の活性酸素消去剤の投与量は、患者の年令、体重、疾患の程度、投与経路により異なるが、経口投与では、アセロラの抽出物乾燥粉末として、通常1日10mg〜3000mgであり、投与回数は、通常、経口投与では1日1回〜3回である。 The dose of the active oxygen scavenger of the present invention varies depending on the patient's age, body weight, degree of disease, and administration route, but in oral administration, it is usually 10 mg to 3000 mg as acerola extract dry powder, The frequency of administration is usually 1 to 3 times a day for oral administration.
経口剤は、例えばデンプン、乳糖、白糖、マンニット、カルボキシメチルセルロース、コーンスターチ、無機塩類等の賦形剤を用いて常法に従って製造される。 Oral preparations are produced according to a conventional method using excipients such as starch, lactose, sucrose, mannitol, carboxymethylcellulose, corn starch, and inorganic salts.
この種の製剤には、適宜前記賦形剤の他に、結合剤、崩壊剤、界面活性剤、滑沢剤、流動性促進剤、矯味剤、着色剤、香料等を使用することができる。 In this type of preparation, a binder, a disintegrant, a surfactant, a lubricant, a fluidity promoter, a corrigent, a colorant, a fragrance and the like can be appropriately used in addition to the above-mentioned excipients.
結合剤の具体例としては、結晶セルロース、結晶セルロース・カルメロースナトリウム、メチルセルロース、ヒドロキシプロピルセルロース、低置換度ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシプロピルメチルセルロースフタレート、ヒドロキシプロピルメチルセルロースアセテートサクシネート、カルメロースナトリウム、エチルセルロース、カルボキシメチルエチルセルロース、ヒドロキシエチルセルロース、コムギデンプン、コメデンプン、トウモロコシデンプン、バレイショデンプン、デキストリン、アルファー化デンプン、部分アルファー化デンプン、ヒドロキシプロピルスターチ、プルラン、ポリビニルピロリドン、アミノアルキルメタクリレートコポリマーE、アミノアルキルメタクリレートコポリマーRS、メタクリル酸コポリマーL、メタクリル酸コポリマー、ポリビニルアセタールジエチルアミノアセテート、ポリビニルアルコール、アラビアゴム、アラビアゴム末、寒天、ゼラチン、白色セラック、トラガント、精製白糖、マクロゴールが挙げられる。 Specific examples of the binder include crystalline cellulose, crystalline cellulose / carmellose sodium, methylcellulose, hydroxypropylcellulose, low-substituted hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxypropylmethylcellulose phthalate, hydroxypropylmethylcellulose acetate succinate, carmellose sodium , Ethylcellulose, carboxymethylethylcellulose, hydroxyethylcellulose, wheat starch, rice starch, corn starch, potato starch, dextrin, pregelatinized starch, partially pregelatinized starch, hydroxypropyl starch, pullulan, polyvinylpyrrolidone, aminoalkyl methacrylate copolymer E, aminoalkyl METAKU Rate copolymer RS, methacrylic acid copolymer L, methacrylic acid copolymer, polyvinyl acetal diethylamino acetate, polyvinyl alcohol, gum arabic, gum arabic powder, agar, gelatin, white shellac, tragacanth, purified sucrose, macrogol.
崩壊剤の具体例としては、結晶セルロース、メチルセルロース、低置換度ヒドロキシプロピルセルロース、カルメロース、カルメロースカルシウム、カルメロースナトリウム、クロスカルメロースナトリウム、コムギデンプン、コメデンプン、トウモロコシデンプン、バレイショデンプン、部分アルファー化デンプン、ヒドロキシプロピルスターチ、カルボキシメチルスターチナトリウム、トラガントが挙げられる。 Specific examples of the disintegrant include crystalline cellulose, methylcellulose, low-substituted hydroxypropylcellulose, carmellose, carmellose calcium, carmellose sodium, croscarmellose sodium, wheat starch, rice starch, corn starch, potato starch, and partially pregelatinized. Starch, hydroxypropyl starch, sodium carboxymethyl starch, tragacanth can be mentioned.
界面活性剤の具体例としては、大豆レシチン、ショ糖脂肪酸エステル、ステアリン酸ポリオキシル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンポリオキシプロピレングリコール、セスキオレイン酸ソルビタン、トリオレイン酸ソルビタン、モノステアリン酸ソルビタン、モノパルミチン酸ソルビタン、モノラウリン酸ソルビタン、ポリソルベート、モノステアリン酸グリセリン、ラウリル硫酸ナトリウム、ラウロマクロゴールが挙げられる。 Specific examples of surfactants include soybean lecithin, sucrose fatty acid ester, polyoxyl stearate, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene glycol, sorbitan sesquioleate, sorbitan trioleate, sorbitan monostearate Sorbitan monopalmitate, sorbitan monolaurate, polysorbate, glyceryl monostearate, sodium lauryl sulfate, lauromacrogol.
滑沢剤の具体例としては、コムギデンプン、コメデンプン、トウモロコシデンプン、ステアリン酸、ステアリン酸カルシウム、ステアリン酸マグネシウム、含水二酸化ケイ素、軽質無水ケイ酸、合成ケイ酸アルミニウム、乾燥水酸化アルミニウムゲル、タルク、メタケイ酸アルミン酸マグネシウム、リン酸水素カルシウム、無水リン酸水素カルシウム、ショ糖脂肪酸エステル、ロウ類、水素添加植物油、ポリエチレングリコールが挙げられる。 Specific examples of lubricants include wheat starch, rice starch, corn starch, stearic acid, calcium stearate, magnesium stearate, hydrous silicon dioxide, light anhydrous silicic acid, synthetic aluminum silicate, dry aluminum hydroxide gel, talc, Examples thereof include magnesium aluminate metasilicate, calcium hydrogen phosphate, anhydrous calcium hydrogen phosphate, sucrose fatty acid ester, waxes, hydrogenated vegetable oil, and polyethylene glycol.
流動性促進剤の具体例としては、含水二酸化ケイ素、軽質無水ケイ酸、乾燥水酸化アルミニウムゲル、合成ケイ酸アルミニウム、ケイ酸マグネシウムが挙げられる。 Specific examples of the fluidity promoter include hydrous silicon dioxide, light anhydrous silicic acid, dry aluminum hydroxide gel, synthetic aluminum silicate, and magnesium silicate.
また、本発明の活性酸素消去剤は、液剤、シロップ剤、懸濁剤、乳剤、エリキシル剤として投与する場合には、矯味矯臭剤、着色剤を含有してもよい。 Moreover, the active oxygen scavenger of this invention may contain a flavoring agent and a coloring agent, when administering as a liquid agent, a syrup agent, a suspension agent, an emulsion, and an elixir.
本発明の活性酸素消去剤はまた、常法に従って、化粧水、乳液、クリーム、パック、洗浄料等のスキンケア化粧料、口紅、ファンデーション等のメーキャップ化粧料、頭髪用化粧料等に添加することができる。 The active oxygen scavenger of the present invention can also be added to skin care cosmetics such as skin lotions, emulsions, creams, packs, cleaning agents, makeup cosmetics such as lipsticks and foundations, hair cosmetics, etc. according to a conventional method. it can.
本発明の活性酸素消去剤はさらに、常法に従って、食品、飴、トローチ、ジャム、チューインガム、飲料等に添加することができる。 The active oxygen scavenger of the present invention can be further added to foods, rice cakes, troches, jams, chewing gums, beverages and the like according to conventional methods.
また、本発明の活性酸素消去剤を抽出物乾燥粉末としてそのまま使用することもできる。さらに、いわゆる特定保健用食品(例えば、動脈硬化予防食品)等とすることもできる。 Moreover, the active oxygen scavenger of this invention can also be used as it is as an extract dry powder. Furthermore, it may be a so-called food for specified health use (for example, food for preventing arteriosclerosis).
本発明の活性酸素消去剤の製造に用いるアセロラ、アントシアニン系色素、ビタミンC及び鉄等の金属は現在までに化粧料、食品等に供されており、安全性は確立されている。 Metals such as acerola, anthocyanin pigments, vitamin C and iron used in the production of the active oxygen scavenger of the present invention have been used in cosmetics, foods, etc., and safety has been established.
以下、実施例により本発明をさらに具体的に説明するが、本発明の範囲はこれらの実施例に限定されるものではない。
実施例1
アセロラの果汁を貯蔵により退色させ、その色素分解物について活性酸素消去活性を評価した。
[試料の調製]
アセロラをガーゼで搾汁し、遠心ろ過後に得られた果汁に、2時間ペクチナーゼを作用させて粘性をなくした。得られた液をフィルター滅菌後、無菌的に40℃で約1ヶ月間インキュベートした。この処理により、アセロラ果汁の赤色は徐々に退色していき、5日後には完全に退色した。インキュベート0、1、3、7、14、21、35日後の退色果汁を、水溶性成分をC18カートリッジカラム(BAKERBOND spe(登録商標)C18 ディスポーザルカラム)に供し、蒸留水で充分に洗浄後、C18カラム吸着画分を0.2% TFA/メタノール溶液で溶出した。得られた溶出液をエバポレーターで濃縮後、カラムに供した退色果汁と同量の蒸留水で再溶解した。以上の操作により得られた試料、及びそれを2倍希釈、4倍希釈した試料について活性酸素消去活性を評価した。
EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples. However, the scope of the present invention is not limited to these examples.
Example 1
The acerola juice was discolored by storage, and the active oxygen scavenging activity of the pigment degradation product was evaluated.
[Sample preparation]
The acerola was squeezed with gauze, and pectinase was allowed to act on the juice obtained after centrifugal filtration for 2 hours to eliminate the viscosity. The obtained liquid was sterilized by filter and incubated aseptically at 40 ° C. for about 1 month. By this treatment, the red color of the acerola juice gradually faded, and after 5 days it completely faded. After 0, 1, 3, 7, 14, 21, and 35 days of incubation, the bleached fruit juice was subjected to a water-soluble component on a C18 cartridge column (BAKERBOND spe (registered trademark) C18 disposable column), thoroughly washed with distilled water, The C18 column adsorption fraction was eluted with 0.2% TFA / methanol solution. The obtained eluate was concentrated with an evaporator and redissolved with distilled water in the same amount as the bleached fruit juice applied to the column. The active oxygen scavenging activity was evaluated for the sample obtained by the above operation and a sample obtained by diluting it twice or 4 times.
[活性酸素消去活性の評価]
活性酸素消去活性は、キサンチン−キサンチンオキシダーゼ反応系によるスーパーオキシドアニオンラジカルの消去活性で評価し、ラジカルの検出はESRを用いた。
[Evaluation of active oxygen scavenging activity]
The active oxygen scavenging activity was evaluated based on the scavenging activity of superoxide anion radicals by a xanthine-xanthine oxidase reaction system, and ESR was used to detect the radicals.
DMPO15μl、50mMリン酸緩衝液(pH7.4) 50μl、試料50μl、2mMヒポキサンチン/リン酸緩衝液溶液50μl、0.4unit/mlキサンチンオキシダーゼ (XOD) / リン酸緩衝液50μlを混合し、XOD添加後45秒後にESR測定を行った。 DMPO 15 μl, 50 mM phosphate buffer (pH 7.4) 50 μl, sample 50 μl, 2 mM hypoxanthine / phosphate buffer solution 50 μl, 0.4 unit / ml xanthine oxidase (XOD) / phosphate buffer 50 μl, and after addition of XOD ESR measurement was performed after 45 seconds.
なお、ESR装置は日本電子社製 ESR (JES-FR30) を用い、ESRによるスペクトル解析は以下の条件で行った:
磁場掃引幅:335.9±5mT、磁場変調:0.1mT、増幅率:100、掃引時間2分、応答時間:0.1秒、測定温度:室温。
The ESR device was ESR (JES-FR30) manufactured by JEOL Ltd., and spectrum analysis by ESR was performed under the following conditions:
Magnetic field sweep width: 335.9 ± 5mT, magnetic field modulation: 0.1mT, gain: 100, sweep time 2 minutes, response time: 0.1 seconds, measurement temperature: room temperature.
測定結果は図1の通りである。図1より、果汁の分解が進むにつれて、活性酸素消去活性が高くなる傾向が見られた。 The measurement results are as shown in FIG. As shown in FIG. 1, the active oxygen scavenging activity tended to increase as the fruit juice decomposition progressed.
実施例2
実施例1より、アセロラ果汁において、分解が進むにつれ活性酸素消去活性が高くなる傾向が見られたが、この系ではアントシアニン系色素以外の成分による影響も考えられるため、アセロラからアントシアニン系色素を精製し、色素精製物を用いた単純系で同様の実験を行った。
Example 2
From Example 1, the acerola juice showed a tendency to increase the active oxygen scavenging activity as the decomposition progressed. In this system, the effect of components other than the anthocyanin dye is also considered, so the anthocyanin dye is purified from the acerola. The same experiment was conducted in a simple system using a purified dye product.
アセロラより精製したアントシアニン系色素、ビタミンC、塩化鉄の最終濃度を、アセロラ果実の含有量に従って、それぞれ0.2、10、0.02mg/mlとなるように0.1M 酢酸バッファー (pH3.0) で調製し、40℃で約1ヶ月間インキュベートした。その後、インキュベート0、7、14、21、28、35日後の調製液をC18カートリッジカラムに供し、蒸留水で充分に洗浄後、C18カラム吸着画分を0.2% TFA/メタノール溶液で溶出した。得られた溶出液をエバポレーターで濃縮後、カラムに供した調製液と同量の蒸留水で再溶解した。以上の操作により得られた試料、及びそれを2倍希釈、4倍希釈、8倍希釈、16倍希釈した試料について活性酸素消去活性を評価した。
活性酸素消去活性の評価方法は実施例1と同様である。
The final concentrations of anthocyanin pigment, vitamin C, and iron chloride purified from acerola are adjusted with 0.1M acetate buffer (pH 3.0) to 0.2, 10, and 0.02 mg / ml, respectively, according to the acerola fruit content. Incubated at 40 ° C. for about 1 month. Thereafter, the prepared solution after 0, 7, 14, 21, 28, and 35 days of incubation was applied to a C18 cartridge column, washed thoroughly with distilled water, and then the C18 column adsorbed fraction was eluted with a 0.2% TFA / methanol solution. The obtained eluate was concentrated with an evaporator and then redissolved with the same amount of distilled water as the prepared solution used for the column. The active oxygen scavenging activity was evaluated for the sample obtained by the above operation and the sample diluted 2 times, 4 times, 8 times and 16 times.
The evaluation method of the active oxygen scavenging activity is the same as in Example 1.
測定結果は図2の通りである。図2より、アセロラ果汁の場合と同様に、色素の分解が進むにつれて、活性酸素消去活性が高くなる傾向が見られた。この実験は単純系で行っており、C18カラムに吸着する成分はアントシアニン系色素分解物に限られる。実際にこの吸着成分についてビタミンC含量を調べたが、ビタミンCは全く検出されなかった。従って、アセロラにおけるアントシアニン系色素は、分解が進むにつれ活性酸素消去活性が高くなることが判った。 The measurement results are as shown in FIG. From FIG. 2, as in the case of acerola juice, the active oxygen scavenging activity tended to increase as the decomposition of the pigment progressed. This experiment is conducted in a simple system, and the components adsorbed on the C18 column are limited to anthocyanin pigment decomposition products. Actually, vitamin C content of this adsorbed component was examined, but no vitamin C was detected. Therefore, it was found that the active oxygen scavenging activity of the anthocyanin dyes in acerola increases as the decomposition proceeds.
実施例3
アセロラ果汁中におけるアントシアニン系色素において、分解が進むにつれ活性酸素消去活性が上昇することがわかったが、一般のアントシアニン系色素でも、同様の結果が得られるかどうか検討を行った。
Example 3
In the anthocyanin pigments in acerola juice, it was found that the active oxygen scavenging activity increased as the decomposition progressed, but it was investigated whether the same results could be obtained with general anthocyanin pigments.
標品のシアニジンクロリドを0.075mg/mlの濃度になるように0.1M酢酸バッファー(pH3.0)に溶かし、ビタミンCを10mg/ml、塩化鉄を0.02mg/ml添加したものを40℃でインキュベートし退色させた。その後、C18カートリッジカラムによりビタミンCを除去し、エタノールでアントシアニン系色素分解物を溶出した。得られた溶出液をエバポレーターで濃縮後、濃度が0.25mg/mlの濃度になるように蒸留水で再溶解した。この試料の活性酸素消去活性を以下のようにDPPH法により評価した。 Standard cyanidin chloride dissolved in 0.1M acetic acid buffer (pH 3.0) to a concentration of 0.075mg / ml, vitamin C added at 10mg / ml, iron chloride added at 0.02mg / ml, incubated at 40 ° C And faded. Thereafter, vitamin C was removed with a C18 cartridge column, and the anthocyanin pigment decomposition product was eluted with ethanol. The obtained eluate was concentrated with an evaporator, and then redissolved with distilled water to a concentration of 0.25 mg / ml. The active oxygen scavenging activity of this sample was evaluated by the DPPH method as follows.
[活性酸素消去活性の評価]
DPPH法で評価を行った。試料0.5mlに0.1M リン酸緩衝液 (pH6.5) 2.5ml、99% エタノール1.0ml、5×10-4M DPPH-エタノール溶液1.0mlを混合し室温に放置した。経時的に525nmの吸光度を測定し、ラジカル消去活性を評価した。
測定結果は図3に示した通りである。図3より退色前と比較して退色後の方が活性が強いことが判った。
[Evaluation of active oxygen scavenging activity]
Evaluation was made by the DPPH method. 0.5 ml of a sample was mixed with 2.5 ml of 0.1 M phosphate buffer (pH 6.5), 1.0 ml of 99% ethanol, and 1.0 ml of 5 × 10 −4 M DPPH-ethanol solution and left at room temperature. Absorbance at 525 nm was measured over time to evaluate radical scavenging activity.
The measurement results are as shown in FIG. From FIG. 3, it was found that the activity after fading was stronger than that before fading.
Claims (1)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003336062A JP4414711B2 (en) | 2003-09-26 | 2003-09-26 | Active oxygen scavenger and method for producing the same |
PCT/JP2004/012951 WO2005030233A1 (en) | 2003-09-26 | 2004-09-06 | Active oxygen scavenging agent and process for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003336062A JP4414711B2 (en) | 2003-09-26 | 2003-09-26 | Active oxygen scavenger and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005104841A JP2005104841A (en) | 2005-04-21 |
JP4414711B2 true JP4414711B2 (en) | 2010-02-10 |
Family
ID=34386086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003336062A Expired - Lifetime JP4414711B2 (en) | 2003-09-26 | 2003-09-26 | Active oxygen scavenger and method for producing the same |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4414711B2 (en) |
WO (1) | WO2005030233A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101171266B (en) * | 2005-02-28 | 2012-05-16 | 株式会社日冷食品 | Acerola fruit-derived pectin and use thereof |
JP4888363B2 (en) * | 2007-12-05 | 2012-02-29 | カルピス株式会社 | Beverage prevention method for beverages |
JP5574600B2 (en) * | 2007-12-17 | 2014-08-20 | 日本製薬工業株式会社 | Preventive and therapeutic agent for resorbable bone disease |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH072640A (en) * | 1992-10-29 | 1995-01-06 | Marino Forum 21 | External preparation for protecting ultraviolet disorder |
JPH09241637A (en) * | 1996-03-14 | 1997-09-16 | Chugai Pharmaceut Co Ltd | Composition for removing active oxygen free radical and removal thereof |
DK0842606T3 (en) * | 1996-11-13 | 2000-06-05 | Procter & Gamble | Disinfecting microemulsions |
JP2000176272A (en) * | 1998-12-16 | 2000-06-27 | House Foods Corp | Production of granulated matter and tablet |
AU6801200A (en) * | 1999-08-27 | 2001-03-26 | Amway Corporation | Dietary food supplement containing natural cyclooxygenase inhibitors |
JP2001329186A (en) * | 2000-05-22 | 2001-11-27 | Tomoko Shimizu | Method for stabilizing anthocyanin-based pigment and product |
JP2002179578A (en) * | 2000-12-14 | 2002-06-26 | Noevir Co Ltd | Antioxidant converted into polymer and skin care preparation comprising the same |
JP4051410B2 (en) * | 2002-05-20 | 2008-02-27 | 弘果弘前中央青果株式会社 | Method for increasing the amount of polyphenol measured by the Folin-Denis method |
-
2003
- 2003-09-26 JP JP2003336062A patent/JP4414711B2/en not_active Expired - Lifetime
-
2004
- 2004-09-06 WO PCT/JP2004/012951 patent/WO2005030233A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2005104841A (en) | 2005-04-21 |
WO2005030233A1 (en) | 2005-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111194219A (en) | Use of polyphenols comprising sugar cane extract for preventing, ameliorating or treating skin problems | |
JPH09506906A (en) | Cosmetic or pharmaceutical composition containing mangiferin or a derivative thereof as an active ingredient in pure form or as a plant extract | |
WO2013100105A1 (en) | Maillard reaction inhibitor | |
US20110207697A1 (en) | Xanthohumol compositions and methods for treating skin diseases or disorders | |
TW201722417A (en) | External dermal agent for reducing yellowish dullness | |
JP2005154432A (en) | Processed acerola containing polyphenol and / or vitamin C | |
JP2002293736A (en) | Maillard reaction inhibitor and composition containing the same | |
AT406935B (en) | METHOD FOR PRODUCING AN OILY PREPARATION | |
JP4451627B2 (en) | Glucose level rise inhibitor and AGE production inhibitor | |
JP5686328B2 (en) | Anti-glycation composition | |
JP4247833B2 (en) | Visual function improver | |
JP2015127339A (en) | Composition for anti-saccharification | |
JP4414711B2 (en) | Active oxygen scavenger and method for producing the same | |
JP6915774B2 (en) | Testosterone increaser | |
KR20160021734A (en) | Antioxidative composition comprising extract of red tea stem | |
JP2019043942A (en) | Method and apparatus for producing microwave dried or aging-drying polygonum tinctorium lour. leaves and use thereof | |
Hongmei | Evaluation of antioxidant activity of polysaccharides isolated from Camellia sinensis (tea) in exhausting training mice | |
JP6678928B2 (en) | Oral beauty agent | |
JP6778026B2 (en) | Whitening agents and whitening foods and drinks containing 4'-demethylnobiletin as an active ingredient | |
JP2002029975A (en) | Free radical scavenger | |
JP4720504B2 (en) | Plant seed extract composition and method for producing the same | |
JP6826397B2 (en) | Microwave dried indigo leaves, their manufacturing methods and their uses | |
JP2015025008A (en) | Anti-glycation composition | |
KR0168721B1 (en) | Method for preparing extract of C. oleracea and its antioxidant, free radical scavenging and antimutagenic agent | |
EP3758799B1 (en) | Composition for the prevention and treatment of skin damages caused by photo-exposure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20050526 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051021 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090714 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090910 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20091104 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20091120 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121127 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4414711 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131127 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |